Search

Erythritol, a natural sweetener, is widely used in the food, medicinal and chemical industries because of its advantages of low calorie, good stability and high food safety. Yarrowia lipolytica is widely used as an efficient fermentation strain for erythritol production. However, the current research on erythritol production by Yarrowia lipolytica concentrates on control of the fermentation process and metabolic pathway regulation and has bottlenecks in the yield of erythritol and the fermentation process. On this basis, this article reviews recent progress in research on erythritol production by Yarrowia lipolytica from three aspects: fermentation substrate utilization, fermentation process control and metabolic pathway modification by genetic engineering. This review is expected to provide a reference for breaking the bottlenecks in erythritol production by Yarrowia lipolytica.

As a phenotypically and phylogenetically diverse group, lactic acid bacteria are found in a variety of natural environments and play an important role in medicine, bioengineering, food fermentation and agriculture. Lactic acid bacteria have a long history of use in food and have been considered as suitable vehicles for the production and targeted delivery of health-promoting or therapeutic bioactive substances due to their safety and probiotic properties, and the operability of their genetic systems. This article summarizes the latest studies on lactic acid bacteria as delivery vehicles in vivo with a focus on gene expression systems of lactic acid bacteria, the expression forms of bioactive substances and the application of lactic acid bacteria as delivery vehicles in the treatment of various diseases. It is hoped that this review will provide a basis for subsequent research.

Previous studies have shown that Lactobacillus plantarum AR495 has good anti-inflammatory and anti-osteoporosis effects. In order to further explore the effect and mechanism of AR495 in alleviating osteoporosis (OA), a rat model of OA was established to investigate the effects of AR495 on OA markers, inflammatory factor levels and oxidative stress injury in OA rats and to verify the recovery of cartilage matrix and bone by pathological staining of joints and microtomography (micro-CT) imaging. The results showed that AR495 could significantly alleviate excessive body mass gain caused by decreased physical activity in OA rats (P < 0.05). Pathological analysis showed that AR495 could significantly reduce the level of tumor necrosis factor-α (TNF-α) in the joint tissue of OA rats, inhibit the production of matrix metalloproteinase-13 (MMP-13) and the production of C-telopeptide of type II collagen (CTX-II) as a degradation product of cartilage matrix, thereby alleviating the degradation of articular cartilage matrix in rats. Micro-CT imaging showed that AR495 could significantly alleviate bone loss in the joint of OA rats and effectively protect the integrity of cartilage and synovium of rats. In addition, AR495 could significantly increase the activity of superoxide dismutase (SOD) and reduce the concentration of malondialdehyde (MDA) in peripheral blood (P < 0.05). Quantitative real-time polymerase chain reaction (qPCR) analysis showed that AR495 could stimulate the expression of the mucin-2 (MUC-2) and occludin-1 genes in intestinal goblet cells and repair the intestinal barrier function. It can be seen that AR495 can alleviate OA inflammation level and create a beneficial internal environment for chondrocytes to exert their functions and produce collagen matrix, thereby alleviating and restoring joint injury and improving OA symptoms.

AbstractType 2 diabetes mellitus (T2DM) is one of the metabolic diseases with the highest morbidity rates in the world. Probiotics have positive health impacts on human health and a considerable amount of research has demonstrated their beneficial effects in treating T2DM. However, probiotic intervention in T2DM has complex mechanisms because the pathogenesis of T2DM is complex. This review summarized the mechanisms of probiotic intervention in diabetes from the perspective of diabetes pathogenesis. First, the objectives of probiotic intervention in diabetes aimed at the intestinal tract reparative effects, pancreatic function, host metabolism and self-recovery were comprehensively reviewed. Next, we concluded the clinical application status of ingested probiotics in patients with T2DM, and an obvious imbalance exists between theoretical probiotic research and clinical applications. Finally, we summarized the emerging research on probiotic interventions in T2DM and analyzed the literature in this regard, including next-generation probiotics; suggestions for probiotics consumption with the aim of diabetic complications; as well as the association between novel mechanisms of diabetes remission with the potential for probiotic intervention. In conclusion, this review sheds light on the potential role of probiotics, from proposed mechanisms to prospects in relieving T2DM. [ABSTRACT FROM AUTHOR]

Certain workplaces, like deep-sea voyages, subject workers to chronic psychological stress and circadian rhythm disorders due to confined environments and frequent shifts. In this study, participants lived in a strictly controlled confined environment, and we analyzed the effects of a confined environment on gut microbiota and metabolites. The results showed that living in confined environments can significantly alter both the gut microbiota and the gut metabolome, particularly affecting lipid metabolism pathways like glycerophospholipid metabolism. There was a significant reduction in the abundance of Faecalibacterium and Bacteroides, while Blautia, Bifidobacterium, and Collinsella showed significant increases. An association analysis revealed a strong correlation between changes in the gut microbiota and the metabolome. Four upregulated lipid metabolites may serve as biomarkers for damage induced by confined environments, and certain gut microbiota alterations, such as those involving Faecalibacterium and Bacteroides, could be potential psychobiotics or therapeutic targets for enhancing mental health in a confined environment. [ABSTRACT FROM AUTHOR]

This study investigates the impact of urea and β-GP on the growth of Streptococcus thermophilus S-3, a bacterium commonly used in industrial fermentation processes. Through a series of growth experiments, transcriptome, metabolome, and omics-based analyses, the research demonstrates that both urea and β-GP can enhance the biomass of S. thermophilus, with urea showing a more significant effect. The optimal urea concentration for growth was determined to be 3 g/L in M17 medium. The study also highlights the metabolic pathways influenced by urea and β-GP, particularly the galactose metabolism pathway, which is crucial for cell growth when lactose is the substrate. The integration of omics data into the genome-scale metabolic model of S. thermophilus, iCH502, allowed for a more accurate prediction of metabolic fluxes and growth rates. The study concludes that urea can serve as a viable substitute for β-GP in the cultivation of S. thermophilus, offering potential cost and efficiency benefits in industrial fermentation processes. The findings are supported by validation experiments with 11 additional strains of S. thermophilus, which showed increased biomass in UM17 medium. [ABSTRACT FROM AUTHOR]